Literature DB >> 8770013

Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis.

M C Moore1, L Rossetti, M J Pagliassotti, M Monahan, C Venable, D Neal, A D Cherrington.   

Abstract

The role of the liver nerves in the disposition of peripherally administered glucose was examined in seven hepatic innervated (HI) and nine hepatic denervated (HD) 42-h-fasted conscious dogs. After a 40-min basal period, there was a 4-h experimental period during which the hepatic glucose load was increased twofold via peripheral glucose infusion. Somatostatin was infused to suppress pancreatic endocrine secretion, and insulin and glucagon were infused intraportally to produce a fourfold increase in insulin and a gradual decrease (approximately 25%) in glucagon. The area under the curve of net hepatic glucose uptake (NHGU) during the glucose infusion period totaled 483 +/- 82 and 335 +/- 32 mg/kg in HD and HI, respectively (P < 0.05). The area under the curve of the hepatic fractional extraction of glucose was 27% greater in HD (P < 0.05). Net hepatic lactate output was similar in the two groups, and net hepatic glycogen synthesis was 3.8 +/- 0.8 vs. 2.7 +/- 0.5 mg.kg dog wt-1.min-1 in HD and HI, respectively (P = 0.13). The direct pathway of glycogen synthesis was responsible for 54-58% of net hepatic glycogen synthesis in both HI and HD (n = 6 for both). In summary 1) NHGU in response to peripheral glucose infusion was approximately 44% greater in HD than in HI, 2) net hepatic glycogen synthesis was enhanced by 41% in HD although the probability of this change was 0.13, and 3) the contribution of the direct pathway to glycogen synthesis was the same in HD and HI. These data are consistent with a role for the liver nerves in regulating the magnitude of NHGU in response to glucose administration. They also indicate that the absence of liver nerves may reduce glycogen turnover during glucose infusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770013     DOI: 10.1152/ajpendo.1996.271.2.E215

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Chronic overeating impairs hepatic glucose uptake and disposition.

Authors:  Katie C Coate; Guillaume Kraft; Masakazu Shiota; Marta S Smith; Ben Farmer; Doss W Neal; Phil Williams; Alan D Cherrington; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-17       Impact factor: 4.310

2.  Hepatic glucose uptake and disposition during short-term high-fat vs. high-fructose feeding.

Authors:  Katie C Coate; Guillaume Kraft; Mary Courtney Moore; Marta S Smith; Christopher Ramnanan; Jose M Irimia; Peter J Roach; Ben Farmer; Doss W Neal; Phil Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-27       Impact factor: 4.310

3.  Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.

Authors:  Mary Courtney Moore; Marta S Smith; Larry L Swift; Anthony H Cincotta; Michael Ezrokhi; Nicholas Cominos; Yahong Zhang; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-27       Impact factor: 4.310

4.  MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucose ingestion and a hyperinsulinemic hyperglycemic clamp.

Authors:  Mary Courtney Moore; Katie C Coate; Melanie Scott; Guillaume Kraft; James E Vath; Thomas E Hughes; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-01-28       Impact factor: 4.310

5.  Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day.

Authors:  Mary Courtney Moore; Marta S Smith; Ben Farmer; Katie C Coate; Guillaume Kraft; Masakazu Shiota; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-04-17       Impact factor: 9.461

6.  A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.

Authors:  Zhibo An; Jason J Winnick; Ben Farmer; Doss Neal; Margaret Lautz; Jose M Irimia; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

Review 7.  FGF1 - a new weapon to control type 2 diabetes mellitus.

Authors:  Emanuel Gasser; Christopher P Moutos; Michael Downes; Ronald M Evans
Journal:  Nat Rev Endocrinol       Date:  2017-06-30       Impact factor: 43.330

8.  A cyclic guanosine monophosphate-dependent pathway can regulate net hepatic glucose uptake in vivo.

Authors:  Zhibo An; Jason J Winnick; Mary C Moore; Ben Farmer; Marta Smith; Jose M Irimia; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

9.  Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs.

Authors:  Katie C Coate; Guillaume Kraft; Jose M Irimia; Marta S Smith; Ben Farmer; Doss W Neal; Peter J Roach; Masakazu Shiota; Alan D Cherrington
Journal:  Diabetes       Date:  2012-10-01       Impact factor: 9.461

10.  Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism.

Authors:  Mary Courtney Moore; Marta S Smith; Vikram P Sinha; John M Beals; M Dodson Michael; Scott J Jacober; Alan D Cherrington
Journal:  Diabetes       Date:  2013-10-02       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.